Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies.
Toss A, Venturelli M, Molinaro E, Pipitone S, Barbieri E, Marchi I, Tenedini E, Artuso L, Castellano S, Marino M, Tagliafico E, Razzaboni E, De Matteis E, Cascinu S, Cortesi L. Toss A, et al. Among authors: cascinu s. Cancers (Basel). 2019 Feb 7;11(2):193. doi: 10.3390/cancers11020193. Cancers (Basel). 2019. PMID: 30736435 Free PMC article.
Emerging antibodies for the treatment of pancreatic cancer.
Andrikou K, Peterle C, Pipitone S, Salati M, Cascinu S. Andrikou K, et al. Among authors: cascinu s. Expert Opin Emerg Drugs. 2017 Mar;22(1):39-51. doi: 10.1080/14728214.2017.1293649. Epub 2017 Feb 28. Expert Opin Emerg Drugs. 2017. PMID: 28253833 Review.
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.
Omarini C, Bettelli S, Caprera C, Manfredini S, Caggia F, Guaitoli G, Moscetti L, Toss A, Cortesi L, Kaleci S, Maiorana A, Cascinu S, Conte PF, Piacentini F. Omarini C, et al. Among authors: cascinu s. Cancer Biol Ther. 2018;19(10):879-886. doi: 10.1080/15384047.2018.1480287. Epub 2018 Aug 1. Cancer Biol Ther. 2018. PMID: 30067438 Free PMC article.
Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?
Cortesi L, Canossi B, Battista R, Pecchi A, Drago A, Dal Molin C, Toss A, De Matteis E, Marchi I, Torricelli P, Cascinu S. Cortesi L, et al. Among authors: cascinu s. Int J Cancer. 2019 Mar 1;144(5):1001-1009. doi: 10.1002/ijc.31794. Epub 2018 Oct 4. Int J Cancer. 2019. PMID: 30098212 Free article.
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status.
Omarini C, Bettelli S, Caprera C, Manfredini S, Barbolini M, Moscetti L, Isca C, Toss A, Barbieri E, Cortesi L, Kaleci S, Maiorana A, Tazzioli G, Cascinu S, Piacentini F. Omarini C, et al. Among authors: cascinu s. J Cancer Res Clin Oncol. 2019 Apr;145(4):821-828. doi: 10.1007/s00432-018-02833-8. Epub 2019 Jan 2. J Cancer Res Clin Oncol. 2019. PMID: 30603906
648 results